levothyroxine 125 ug
1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid‑Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use: Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium may induce hyperthyroidism [see Warnings and Precautions (5.1) ]. Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine sodium tablets are a L-thyroxine (T4) indicated in adult and pediatric patients, including neonates, for: Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. (1) Pituitary Thyrotropin (Thyroid‑Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. (1) Limitations of Use: not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis
accord healthcare inc.
ROUND BROWN P 7
Related Pills
levothyroxine 25 ug
accord healthcare inc.
levothyroxine 175 ug
accord healthcare inc.
levothyroxine 50 ug
accord healthcare inc.
levothyroxine 125 ug
accord healthcare inc.
levothyroxine 200 ug
accord healthcare inc.
allopurinol tablet
sun pharmaceutical industries, inc.
diclofenac sodium tablet delayed release
pack pharmaceuticals, llc
diclofenac 75 mg
rising pharmaceuticals, inc.
diclofenac 75 mg
rising pharmaceuticals, inc.
diclofenac sodium tablet delayed release
pack pharmaceuticals, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING All tablets having functional scoring.
LEVOTHYROXINE SODIUM, USP tablets are supplied as follows (Table 11): Table 11:
LEVOTHYROXINE SODIUM Tablet Presentations Strength (mcg) Tablet Description NDC# for bottles with child-resistant closure of 90 NDC # for bottles of 1000 25 round shaped, orange colored, uncoated tablets, break line on both side and debossed with "P" and "1" on one side and plain on other side. 16729-447-15 16729-447-17 50 round shaped, white colored, uncoated tablets, break line on both side and debossed with "P" and "2" on one side and plain on other side. 16729-448-15 16729-448-17 75 round shaped, violet colored, uncoated tablets, break line on both side and debossed with "P" and "3" on one side and plain on other side. 16729-449-15 16729-449-17 88 round shaped, olive colored, uncoated tablets, break line on both side and debossed with "P" and "4" on one side and plain on other side. 16729-450-15 16729-450-17 100 round shaped, yellow colored, uncoated tablets, break line on both side and debossed with "P" and "14" on one side and plain on other side. 16729-451-15 16729-451-17 112 round shaped, Rose colored, uncoated tablets, break line on both side and debossed with "P" and "6" on one side and plain on other side. 16729-452-15 16729-452-17 125 round shaped, brown colored, uncoated tablets, break line on both side and debossed with "P" and "7" on one side and plain on other side. 16729-453-15 16729-453-17 137 round shaped, turquoise colored, uncoated tablets, break line on both side and debossed with "P" and "8" on one side and plain on other side. 16729-454-15 16729-454-17 150 round shaped, blue colored, uncoated tablets, break line on both side and debossed with "P" and "9" on one side and plain on other side. 16729-455-15 16729-455-17 175 round shaped, lilac colored, uncoated tablets, break line on both side and debossed with "P" and "10" on one side and plain on other side. 16729-456-15 16729-456-17 200 round shaped, pink colored, uncoated tablets, break line on both side and debossed with "P" and "11" on one side and plain on other side. 16729-457-15 16729-457-17 300 round shaped, green colored, uncoated tablets, break line on both side and debossed with "P" and "12" on one side and plain on other side. 16729-458-15 16729-458-17 Storage Conditions Store
LEVOTHYROXINE SODIUM tablets at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) (see USP Controlled Room Temperature).
LEVOTHYROXINE SODIUM tablets should be protected from light and moisture.
More pills like ROUND P 7